EuroPCR 2022 – Together again!

The clinical foundations for interventional cardiology practice: today and for the future

Throughout 4 days, Paris was the centre of the interventional cardiology universe with 11,000 attendees participating in EuroPCR 2022 from around the world. Building on the lessons learned about online delivery during the COVID pandemic, EuroPCR was redesigned with a unique blended approach offering a seamless educational experience. This could be seen in the fluidity of the contact between speakers, audience and content, and which sets the future standard for continuing medical education.

Created by and for its participants, innovation, research and sharing knowledge remain the driving force that animates EuroPCR and forms the basis of the ongoing commitment to bring together a community of specialists dedicated to advancing cardiovascular medicine and ensuring the highest level of patient-centred healthcare.

With its intensively developed and attractive content, accented by the creative organisation of the virtual and physical meeting space that encouraged interaction and learning, EuroPCR 2022 offered the 11,000 participants – whether in person or online – a wide gamut of activities covering all fields of interest.

Key topics included:

• World Hypertension Day, and hotlines presenting the latest data concerning the increasingly effective implementation of renal denervation.
• We CARE, a joint initiative of PCR and Stent – Save a Life!, who presented their first published analysis from the UK “Individual cardiovascular health and the economic costs of a pandemic”. Spanish, American and Italian papers will follow, with a French study now underway.
• Women as One, an organisation founded by interventional cardiologists Roxana Mehran and Marie-Claude Morice to promote talented women in medicine, “providing women physicians with unique professional opportunities” and building “a more inclusive, diverse and just workforce in medicine.”
• The European Bifurcation Club sessions with far-ranging discussions on state-of-the-art treatment of coronary artery disease and chronic total occlusions, among others.
• Treating structural heart disease today, the evolution and continued importance of the Heart Team; with sessions on the present and future of TAVI, valve durability, tricuspid and mitral interventions, risk stratification.
• Intracoronary physiology, the latest in imaging, artificial intelligence and robotics, treating MINOCA and more.

Celebrations:

• The 20-year anniversary of the first transcatheter aortic valve implantation (TAVI) in man performed by Prof. Alain Cribier
• 30 years of the radial approach, pioneered by Ferdinand Kiemeneij
• 10 years of the PCR-EAPCI Textbook
• 200 issues of EuroIntervention

Innovation: the centre of interventional cardiology

For the first time, at EuroPCR 2022, “Innovators Day” was not a separate day, but integrated into the scientific programme itself. The goal, to facilitate finding answers to unmet clinical needs, created a dynamic process that brought together inventors, investors, innovators and clinicians.

The Jon DeHaan Foundation Award ($200,000) for ground-breaking contributions to cardiovascular research and medical innovation was given to Jiayue Huang on behalf of Shengxian Tu (School of biomedical engineering, Shanghai Jiaotong University and Pulse Medical, China) for work on the “Real-time comprehensive assessment of coronary physiology and biomechanics from a single angiographic projection”.

The Abbott Award for best personalised care project went to Domenico D'Amari, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy for “Myocardial bridge evaluation towards personalised medicine: The RIALTO registry”

The Andreas Grüntzig Ethica Award paid tribute to the essential role played in the interventional cardiovascular community by Nurses and Allied Professionals.

EuroPCR 2022 Awards for:

• Best clinical case - Fadi Sawaya, Beirut, Lebanon for “Early transcatheter aortic valve failure in a young inoperable patient”
• PCR’s Got Talent - Arif Khokhar, Imperial College Healthcare NHS Trust, London, United Kingdom for “Coronary access after valve-in-valve TAVI with ACURATE neo: ex vivo analysis”

The EAPCI-PCR Fellows Course, traditionally held the day before EuroPCR, was spread out across the 4 days, allowing participants to benefit from total immersion and creating valuable networking opportunities.

The European Association of Percutaneous Cardiovascular Interventions (EAPCI) 2021 Grant programme, presented by EAPCI President, Emanuele Barbato:

• Kamil Bujak from Poland to work at the Hospital Clinic, Barcelona, Spain (Sponsor: Boston Scientific)
• Francesco Fracassi from Italy to work at Barts Heart Centre, St. Bartolomew Hospital, London, UK sponsored by (Boston Scientific)
• Marcos Manuel Garcia Guimaraesfrom Spain to work at St. Antonius Hospital, Nieuwegein, The Netherlands (Medtronic)
• Domagoj Markovic from Croatia to work at the University Hospital of Zurich, Switzerland (Terumo)
• Anastasios Alexandros Siskosfrom Greece to work at the Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands (Sponsor: Abiomed)
• Tatyana Storozhenko from the Ukraine to work at the Cardiovascular Center OLV, Aalst, Belgium (Cardinal Health)
• Maarten Vanhaverbeke from Croatia to work at the University Hospital of Zurich, Switzerland (Medtronic)
• Mariana Goncalves from Portugal to work at the Clinique Pasteur, Toulouse, France (Edwards Lifesciences)
• Blanca Trejo Velasco from Spain to work at the Heart Centre Leipzig, Germany (Edwards Lifesciences)

Building the future through continuity: PCR and EuroPCR don’t end with the closing of the annual Course!

How do you create the balance between research and practice?
How do you translate clinical data into clinical applications?

One answer is the dialogue that takes place at EuroPCR and continues well after the annual meeting ends, online at PCRonline, in the pages of EuroIntervention and in the many other Courses and opportunities that define the PCR family, from the PCR seminars to the seminal PCR Companions programme.

Upcoming PCR meetings include:

• AICT-AsiaPCR 6-8 October 2022
• PCR London Valves 27-29 November 2022
• PCR-CIT China Chengdu Valves 4-6 November 2022
• GulfPCR-GIM 14-15 December 2022
• PCR Tokyo Valves 17-19 February 2023
• AfricaPCR

And EuroPCR 2022 is still available on demand for 3 months following the Course.

Next year, EuroPCR 2023 will take place on 16 – 19 May

NOTES TO EDITORS

About EuroPCR 2022

The World-Leading Course in interventional cardiovascular medicine and the official annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) will take place from 17 to 20 May 2022, in Paris and online. The detailed Course Programme is available on: www.pcronline.com/Courses/EuroPCR/Programme/2022/Course-Programme

About PCR

The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. PCR offers a large range of many other educational meetings and resources for the continuing education of the interventional cardiovascular community. These include major annual Courses across the globe, e-Learning with high-profile PCR Webinars, Courses specifically dedicated to valvular heart disease, tailor-made PCR Seminars on specific topics, online resources and medical publications such as EuroIntervention, the official journal of the EAPCI.

Gateways to all PCR activities are available on www.pcronline.com

For further information, please contact Sally Collingridge: [email protected]

About the EAPCI

The European Association of Percutaneous Cardiovascular Interventions (EAPCI) is a branch of the European Society of Cardiology. Its mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions. This dynamic association represents a community of over 7,000 healthcare professionals by helping them remain up to date in the constantly evolving field of PCI by publishing research and providing training and certification programmes. The EAPCI also advocates for the best possible access to life saving treatments for patients through data-based advocacy at a European level.

EuroPCR press releases can be found at: https://www.pcronline.com/News/PCR-Press-Releases

For any press-related enquiries, please contact: EuroPCR Press Coordinator, Isabelle Uzielli: [email protected] 

About We CARE

www.wecareabouthearts.org

Activities can be followed on social medial using the hashtag: #WeCareAboutHearts https://twitter.com/WeCareAboutHea1 https://www.linkedin.com/company/wecareabouthearts For further information, please contact Sandrine Wallace: [email protected]

About Stent – Save a Life!

The Stent – Save a Life! global initiative aims to improve access to guideline-complying therapy and the lifesaving indication of primary percutaneous coronary intervention (p-PCI), thereby reducing mortality and morbidity in patients suffering from acute myocardial infarction (AMI). More details of Stent – Save a Life! activities can be found here: www.stentsavealife.com For further information, please contact Sandrine Wallace: [email protected]

World Hypertension Day: www.whleague.org/about-us/world-hypertension-day

Woman as One: www.womenasone.org

Jon DeHaan Foundation: www.jondehaanfoundation.org